BioSyent Inc.
RX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.56% | 18.94% | 13.33% | 12.80% | 9.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.56% | 18.94% | 13.33% | 12.80% | 9.17% |
| Cost of Revenue | 37.84% | 30.23% | 22.15% | 23.62% | 17.93% |
| Gross Profit | 16.10% | 16.02% | 11.10% | 10.16% | 7.12% |
| SG&A Expenses | 14.40% | 8.23% | 5.10% | 5.98% | 1.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.91% | 14.18% | 9.68% | 10.58% | 5.54% |
| Operating Income | 19.57% | 34.02% | 24.49% | 19.52% | 20.87% |
| Income Before Tax | 20.52% | 22.33% | 13.86% | 9.04% | 12.87% |
| Income Tax Expenses | 17.76% | 35.27% | 19.63% | 14.47% | 19.21% |
| Earnings from Continuing Operations | 21.47% | 18.18% | 11.99% | 7.27% | 10.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.47% | 18.18% | 11.99% | 7.27% | 10.83% |
| EBIT | 19.57% | 34.02% | 24.49% | 19.52% | 20.87% |
| EBITDA | 21.50% | 33.77% | 23.49% | 19.03% | 19.75% |
| EPS Basic | 24.98% | 21.76% | 15.25% | 10.58% | 14.09% |
| Normalized Basic EPS | 18.88% | 30.58% | 21.72% | 17.04% | 21.26% |
| EPS Diluted | 24.61% | 21.54% | 14.96% | 10.28% | 14.04% |
| Normalized Diluted EPS | 18.49% | 30.23% | 21.30% | 16.75% | 21.18% |
| Average Basic Shares Outstanding | -2.80% | -2.93% | -2.76% | -3.01% | -3.05% |
| Average Diluted Shares Outstanding | -2.48% | -2.66% | -2.48% | -2.84% | -3.05% |
| Dividend Per Share | 8.90% | 8.24% | 8.37% | 8.50% | 10.79% |
| Payout Ratio | -0.13% | -0.11% | -0.06% | -0.02% | -0.03% |